Trouver des essais cliniques
VOS CRITÈRES DE RECHERCHES - 49 RESULTAT(S)
Total Marrow Irradiation & Autologous Stem Cell Transplantation for Relapsed or Refractory Myeloma
Phase d'étude: Phase 1/Phase 2
Statut du recrutement: En cours
The Ottawa Hospital, Ottawa, Ontario – En cours
Collection of Tissue Samples for Cancer Research
Phase d'étude:
Statut du recrutement: En cours
Princess Margaret Hospital Cancer Centre, Toronto, – Complet
Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Phase d'étude: Phase 1/Phase 2
Statut du recrutement: En cours
University Health Network - Princess Margaret Cancer Center, Toronto, Ontario – Recrutement inactif
Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)
Phase d'étude:
Statut du recrutement: En cours
Local Institution - 0065, Toronto, Ontario – Retiré
Local Institute, Toronto, Ontario – En cours
Local Institution - 0066, Toronto, Ontario – Complet
Autres centres
Local Institute, Weston, Ontario – En cours
Dose-Escalation Study of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)
Phase d'étude: Phase 1
Statut du recrutement: En cours
University of Calgary, Calgary, Alberta – En cours
Princess Margaret Cancer Center, Toronto, Ontario – En cours
Jewish General Hospital, Montreal, Quebec – En cours
Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
Phase d'étude: Phase 2
Statut du recrutement: En cours
Cross Cancer Institute, Edmonton, Alberta – En cours
BCCA - Cancer Centre for the Southern Interior, Kelowna, British Columbia – Suspendu
BCCA - Vancouver Cancer Centre, Vancouver, British Columbia – En cours
Autres centres
Kingston Health Sciences Centre, Kingston, Ontario – En cours
London Regional Cancer Program, London, Ontario – En cours
Ottawa Hospital Research Institute, Ottawa, Ontario – En cours
University Health Network, Toronto, Ontario – En cours
The Jewish General Hospital, Montreal, Quebec – En cours
Allan Blair Cancer Centre, Regina, Saskatchewan – En cours
Saskatoon Cancer Centre, Saskatoon, Saskatchewan – En cours
Liquid Biopsy Evaluation and Repository Development at Princess Margaret
Phase d'étude:
Statut du recrutement: En cours
Princess Margaret Cancer Centre, Toronto, Ontario – En cours
Multi-Center Study of GSK2857916 in Combination With Pomalidomide and Dex
Phase d'étude: Phase 1/Phase 2
Statut du recrutement: En cours
Cross Cancer Institute, Edmonton, Alberta – En cours
Vancouver General Hospital, Vancouver, British Columbia – En cours
CancerCare Manitoba, Winnipeg, Manitoba – En cours
Autres centres
QEII Health Sciences Centre, Halifax, Nova Scotia – En cours
Juravinski Cancer Centre, Hamilton, Ontario – En cours
London Health Sciences Centre, London, Ontario – En cours
The Ottawa Hospital, Ottawa, Ontario – En cours
Princess Margaret Cancer Centre, Toronto, Ontario – En cours
Allan Blair Cancer Centre, Regina, Saskatchewan – En cours
A Study to Determine the Recommended Dose and Regimen and to Evaluate the Safety and Preliminary Efficacy of CC-92480 in Combination With Standard Treatments in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) and Newly Diagnosed Multiple Myeloma (NDMM)
Phase d'étude: Phase 1/Phase 2
Statut du recrutement: En cours
Local Institution - 201, Calgary, Alberta – En cours
Local Institution - 205, Edmonton, Alberta – En cours
Local Institution - 204, Halifax, Nova Scotia – En cours
Autres centres
Local Institution - 203, Toronto, Ontario – En cours
Local Institution - 202, Montreal, Quebec – En cours
Feasibility Study Comparing Enteral vs Parenteral Nutritional Outcomes in Autologous Stem Cell Transplant Patients
Phase d'étude: N/A
Statut du recrutement: En cours
London Health Sciences Centre-Victoria Hospital, London, Ontario – En cours
S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration
Phase d'étude: Phase 3
Statut du recrutement: En cours
BCCA-Vancouver Cancer Centre, Vancouver, British Columbia – Suspendu
Atlantic Health Sciences Corporation-Saint John Regional Hospital, Saint John, New Brunswick – Suspendu
Kingston Health Sciences Centre, Kingston, Ontario – Suspendu
Autres centres
Lakeridge Health Oshawa, Oshawa, Ontario – Suspendu
Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple Myeloma
Phase d'étude: Phase 1
Statut du recrutement: En cours
GSK Investigational Site, Edmonton, Alberta – En cours
GSK Investigational Site, London, Ontario – Complet
Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
Phase d'étude: Phase 1/Phase 2
Statut du recrutement: En cours
GSK Investigational Site, Edmonton, Alberta – En cours
GSK Investigational Site, Vancouver, British Columbia – En cours
GSK Investigational Site, Halifax, Nova Scotia – En cours
Autres centres
GSK Investigational Site, Toronto, Ontario – En cours
A Multicentre, Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home Environment
Phase d'étude: Phase 2
Statut du recrutement: En cours
Tom Baker Cancer Centre, Calgary, Alberta – En cours
Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma
Phase d'étude: Phase 3
Statut du recrutement: En cours
GSK Investigational Site, Ottawa, Ontario – En cours
GSK Investigational Site, Toronto, Ontario – En cours
GSK Investigational Site, Montreal, – En cours
A Study of the Combination of Talquetamab and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Phase d'étude: Phase 1/Phase 2
Statut du recrutement: En cours
Tom Baker Cancer Centre, Calgary, Alberta – En cours
Alberta Health Services, Edmonton, Alberta – En cours
Princess Margaret Cancer Centre University Health Network, Toronto, Ontario – En cours
Autres centres
McGill University Health Centre, Montreal, Quebec – En cours
A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma
Phase d'étude: Phase 1
Statut du recrutement: En cours
Hamilton Health Sciences, Hamilton, Ontario – En cours
University Health Network; Princess Margaret Hospital; Medical Oncology Dept, Toronto, Ontario – En cours
A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy
Phase d'étude: Phase 3
Statut du recrutement: En cours
Tom Baker Cancer Centre, Calgary, Alberta – Recrutement inactif
Vancouver General Hospital, Vancouver, British Columbia – Recrutement inactif
Juravinski Cancer Centre, Hamilton, Ontario – Recrutement inactif
Autres centres
Princess Margaret Cancer Centre University Health Network, Toronto, Ontario – Recrutement inactif
Hopital Maisonneuve-Rosemont, Montréal, Quebec – Recrutement inactif
A Phase 1b/2 Study of BGB-11417in Monotherapy and in Various Combinations With Dexamethasone and Carfilzomib in Multiple Myeloma
Phase d'étude: Phase 1/Phase 2
Statut du recrutement: En cours
Cross Cancer Institute, Edmonton, Alberta – En cours
British Columbia Cancer Agency the Vancouver Centre, Vancouver, British Columbia – En cours
Princess Margaret Cancer Centre, Toronto, Ontario – En cours
Autres centres
Jewish General Hospital, Montreal, Quebec – En cours
Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Phase d'étude: Phase 3
Statut du recrutement: En cours
Tom Baker Cancer Centre, Calgary, Alberta – En cours
Local Institution - 103, Edmonton, Alberta – Complet
BC Cancer Agency, Fraser Valley Center, Surrey, British Columbia – En cours
Autres centres
Local Institution - 104, Saint John, New Brunswick – Complet
Memorial University of NewfoundlandDr. H Bliss Murphy Cancer Center, St John's, Newfoundland and Labrador – En cours
Queen Elizabeth Ii Health Sciences Centre, Halifax, Nova Scotia – En cours
Local Institution - 109, Ottawa, Quebec – Complet
Local Institution - 107, Saskatoon, Saskatchewan – Complet
CHU de Quebec-Universite Laval, Quebec, – En cours
MagnetisMM-5: Study of Elranatamab (PF-06863135) Monotherapy and Elranatamab + Daratumumab Versus Daratumumab + Pomalidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Phase d'étude: Phase 3
Statut du recrutement: En cours
Tom Baker Cancer Center, Calgary, Alberta – Recrutement inactif
Cross Cancer Institute, Edmonton, Alberta – Recrutement inactif
QEII Health Sciences Centre - Victoria General Site, Halifax, Nova Scotia – Recrutement inactif
Autres centres
Queen Elizabeth II Health Science Centre, Halifax, Nova Scotia – Recrutement inactif
Hamilton Health Sciences-Juravinski Cancer Centre, Hamilton, Ontario – Recrutement inactif
Princess Margaret Cancer Centre, Toronto, Ontario – Recrutement inactif
Jewish General Hospital, Montreal, Quebec – Recrutement inactif
CIUSSS de l'Est-de-l'Île-de-Montréal, Montréal, Quebec – Recrutement inactif
Saskatoon Cancer Center, Saskatoon, Saskatchewan – Recrutement inactif
Study to Investigate Alternative Dosing Regimens of Belantamab Mafodotin in Participants With Relapsed or Refractory Multiple Myeloma
Phase d'étude: Phase 2
Statut du recrutement: En cours
GSK Investigational Site, Oshawa, Ontario – En cours
GSK Investigational Site, Toronto, Ontario – En cours
GSK Investigational Site, Montreal, Quebec – En cours
Autres centres
GSK Investigational Site, Montréal, Quebec – En cours
MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple Myeloma
Phase d'étude: Phase 2
Statut du recrutement: En cours
Tom Baker Cancer Center, Calgary, Alberta – En cours
The Ottawa Hospital - General Campus, Ottawa, Ontario – En cours
Princess Margaret Cancer Centre, Toronto, Ontario – En cours
Early Integration of Palliative and Supportive Care in Cellular Therapy
Phase d'étude: N/A
Statut du recrutement: En cours
Tom Baker Cancer Centre, Calgary, Alberta – En cours
Study of ORIC-533 in Relapsed or Refractory Multiple Myeloma
Phase d'étude: Phase 1
Statut du recrutement: En cours
Princess Margaret Cancer Research Center/University Health Network, Toronto, Ontario – En cours
A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma
Phase d'étude: Phase 3
Statut du recrutement: En cours
Tom Baker Cancer Center, Calgary, – À venir
Cross Cancer Institute, Edmonton, – À venir
McMaster University, Hamilton, – À venir
Autres centres
Hopital Maisonneuve-Rosemont, Montréal, – À venir
Mcgill University Health Centre, Montréal, – À venir
Ottawa Hospital Research Institute, Ottawa, – À venir
(CHU) Centre Hospitalier Universitaire de Quebec Laval, Québec, – À venir
Princess Margaret Cancer Centre, Toronto, – À venir
Vancouver General Hospital, Vancouver, – À venir
Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant
Phase d'étude: Phase 3
Statut du recrutement: En cours
Tom Baker Cancer Center, Calgary, Alberta – En cours
Dr. Everett Chalmers Regional Hospital, Fredericton, New Brunswick – En cours
Saint John Regional Hospital, Saint John, New Brunswick – En cours
Autres centres
Hamilton Health Sciences Corporation, Hamilton, Ontario – En cours
Princess Margaret Cancer Centre, Toronto, Ontario – En cours
Windsor Regional Hospital Cancer Program, Windsor, Ontario – À venir
Centre Integre Universitaire de la Santé et de Services Sociaux de l'Est-de-l'ile-de-Montreal,, Montreal, Quebec – En cours
McGill University Health Centre, Montreal, Quebec – En cours
Centre intégré universitaire de santé et de services sociaux du Nord-de-l'Île-de-Montréal (CIUSS, Montreal, Quebec – En cours
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
Phase d'étude: Phase 1/Phase 2
Statut du recrutement: En cours
Alberta Health Services AHS - Foothills Medical Centre FMC, Calgary, Alberta – En cours
University of Alberta - Cross Cancer Institute, Edmonton, Alberta – En cours
University Health Network UHN - Princess Margaret Hospital PMH, Toronto, Ontario – En cours
SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM
Phase d'étude: Phase 3
Statut du recrutement: En cours
Investigational Site Number : 1240001, Toronto, Ontario – En cours
Investigational Site Number : 1240004, Greenfield Park, Quebec – En cours
Investigational Site Number : 1240003, Montreal, Quebec – En cours
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Phase d'étude: Phase 3
Statut du recrutement: En cours
Centre Intégré de Santé et de Services Sociaux de la Montérégie-Centre, Greenfield Park, Quebec – En cours
Centre intégré universitaire de santé et de services sociaux du Nord-de-l'Île-de-Montréal (CIUSSS NÎM) - Hôpital du Sacré-Coeur, Montreal, Quebec – En cours
Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus, Quebec City, Quebec – En cours
A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)
Phase d'étude: Phase 3
Statut du recrutement: En cours
QEII Health Sciences Centre - Victoria General Site, Halifax, Nova Scotia – En cours
Victoria Hospital & Children's Hospital - London Health Sciences Centre, London, Ontario – En cours
Princess Margaret Cancer Centre, Toronto, Ontario – En cours
Autres centres
Local Institution - 0186, Montreal, Quebec – Retiré
A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma
Phase d'étude: Phase 3
Statut du recrutement: En cours
Tom Baker Cancer Centre, Calgary, Alberta – En cours
Saint John Regional Hospital, Saint John, New Brunswick – En cours
Brampton Civic Hospital, Brampton, Ontario – En cours
Autres centres
Lakeridge Health Oshawa, Oshawa, Ontario – En cours
CIUSSS de l'Est-de-l'Île-de-Montréal Installation Hôpital Maisonneuve-Rosemont, Montreal, Quebec – En cours
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135), Daratumumab, and Lenalidomide Compared With Daratumumab, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Phase d'étude: Phase 3
Statut du recrutement: En cours
QEII Health Sciences Centre, Halifax, Nova Scotia – En cours
Princess Margaret Cancer Centre, Toronto, Ontario – En cours
LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study
Phase d'étude:
Statut du recrutement: En cours
Edith Pituskin, Edmonton, Alberta – En cours
A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed or Refractory Multiple Myeloma
Phase d'étude: Phase 1
Statut du recrutement: En cours
Juravinski Cancer Centre /ID# 252053, Hamilton, Ontario – En cours
Ottawa Hospital Research Institute /ID# 252151, Ottawa, Ontario – En cours
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
Phase d'étude: Phase 1
Statut du recrutement: En cours
University Health Network (UHN) - Princess Margaret Cancer Centre (Princess Margaret Hospital), Toronto, Ontario – En cours
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
Phase d'étude: Phase 3
Statut du recrutement: En cours
University Health Network (UHN) - Princess Margaret Cancer Centre, Toronto, Ontario – En cours
A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma
Phase d'étude: Phase 3
Statut du recrutement: En cours
Cross Cancer Institute, Edmonton, Alberta – En cours
The Ottawa Hospital - General Campus, Ottawa, Ontario – En cours
Local Institution - 0307, Montreal, Quebec – À venir
Autres centres
CHUQ - The Hôtel-Dieu de Québec, Quebec, – En cours
A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation
Phase d'étude: Phase 3
Statut du recrutement: En cours
Local Institution - 0133, Edmonton, Alberta – À venir
Hamilton Health Sciences-Juravinski Cancer Centre, Hamilton, Ontario – En cours
Local Institution - 0134, Montreal, Quebec – À venir
A Study Evaluating Safety, Tolerability, and Clinical Activity of Forimtamig-Based Treatment Combinations in Participants With Relapsed or Refractory Multiple Myeloma
Phase d'étude: Phase 1/Phase 2
Statut du recrutement: En cours
Hamilton Health Sciences, Hamilton, Ontario – En cours
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
Phase d'étude: Phase 4
Statut du recrutement: En cours
Tom Baker Cancer Center, Calgary, Alberta – En cours
Cross Cancer Institute, Edmonton, Alberta – En cours
McGill University Health Centre, Montréal, Quebec – En cours
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory Multiple Myeloma
Phase d'étude: Phase 1/Phase 2
Statut du recrutement: En cours
Research Site, Hamilton, Ontario – À venir
Research Site, Montreal, Quebec – À venir
Fixed Duration vs Continuous Daratumumab in Transplant Ineligible Older Adults With Newly Diagnosed Multiple Myeloma
Phase d'étude: Phase 3
Statut du recrutement: En cours
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario – En cours
A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide
Phase d'étude: Phase 3
Statut du recrutement: En cours
Juravinski Cancer Centre, Hamilton, Ontario – En cours
University Health Network (UHN) Princess Margaret Cancer Centre, Toronto, Ontario – En cours
CIUSSS de l'Est-de-l'Île-de-Montréal Installation Hôpital Maisonneuve-Rosemont, Montreal, Quebec – En cours
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)
Phase d'étude: Phase 1
Statut du recrutement: En cours
Dr. Everett Chalmers Regional Hospital, Fredericton, New Brunswick – En cours
Preliminary Assessment of [18F]BL40 in PET/CT Scans
Phase d'étude:
Statut du recrutement: À venir
BC Cancer, Vancouver, British Columbia – ()
A Study to Evaluate Efficacy and Safety of Alnuctamab Compared to Standard of Care Regimens in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Phase d'étude: Phase 3
Statut du recrutement: À venir
Local Institution - 0417, Calgary, Alberta – ()
Local Institution - 0423, Edmonton, Alberta – ()
Local Institution - 0402, London, Ontario – ()
Autres centres
Local Institution - 0395, Toronto, Ontario – ()
Local Institution - 0031, Montreal, Quebec – ()
Local Institution - 0098, Montréal, Quebec – ()
Prehab Prior to Stem Cell Transplantation in Multiple Myeloma
Phase d'étude: N/A
Statut du recrutement: À venir
University of Alberta/ Cross Cancer Institute, Edmonton, Alberta – ()
Study of BMS-986393 a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Phase d'étude: Phase 2
Statut du recrutement: En cours
Local Institution - 0020, Calgary, Alberta – À venir
Local Institution - 0021, Montréal, Quebec – À venir